Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arvin AM. Aspects of the host response to varicella-zoster virus: a review of recent observations. Neurology 1995; 45: S36–37.
Rowbotham M. From mechanisms to clinical syndromes: a comparison of post-herpetic neuralgia and complex regional pain syndromes (RSD and causalgia). Pain symposium. American Academy of Neurology 48th Annual Meeting, San Francisco, March 24, 1996: 1-36.
Oxman MN. Immunization to reduce the frequency and severity of herpes zoster and its complications. Neurology 1995; 45: S41–46.
Pavan-Langston D. Herpes zoster ophthalmicus. Neurology 1995; 45: S50–51.
Kost RG, Straus SE. Postherpetic neuralgia—pathogenesis, treatment, and prevention. N Eng J Med 1996; 335: 32–42.
Bowsher D. Pathophysiology of postherpetic neuralgia: towards a rational treatment. Neurology 1995; 45:S56–57.
Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann Int Med 1995; 123: 89–96.
Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39: 1546–1553.
Valacyclovir. Med Lett Drugs Ther 1996; 38: 3,4.
Whitley RJ. Sorivudine: a promising drug for the treatment of varicella-zoster virus infection. Neurology 1995; 45: S73–75.
Tyring SK. Early treatment of herpes zoster. Hospital Practice 1996; 31: 137–144.
Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandai BK, Crooks J. A randomized trial of acyclovir for 7 days of 21 days with and without prednisolone for treatment of acute herpes zoster. N Eng J Med 1994; 330: 896–900.
Whitley RJ, Weiss H, Gnann JW Jr, Tyring S, Mertz GJ, Pappas PG, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Int Med 1996; 125: 376–383.
Kuter BJ, Weibel RE, Guess HA, et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9: 643–647.
Varicella vaccine. Med Lett Drugs Ther 1995; 37: 55–57.
American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for the use of live attenuated varicella vaccine. Pediatrics 1995; 95: 791–796.
Merskey H, Bogduk N, eds. Classification of chronic pain. 2nd ed. Seattle: IASP, 1994.
Bruxelle J. Prospective epidemiologic study of painful and neurologic sequelae induced by herpes zoster in patients treated early with oral acyclovir. Neurology 1995; 45: S78,79.
Johnson RW. The future of predictors, prevention, and therapy in postherpetic neuralgia. Neurology 1995; 45:S70–72.
Rowbotham MC. Managing post-herpetic neuralgia with opioids and local anesthetics. Ann Neurol 1994; 35:S46–49.
Rowbotham MC, Fields HL. Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature. Pain 1989; 39: 129–144.
Watson CPN. The treatment of postherpetic neuralgia. Neurology 1995; 45: S58–S60.
Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol 1994; 35: S50–53.
Watson CPN, Tyler KL, Bickers DR. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 1993; 15: 510–526.
Boon RJ, Griffin DRJ. Efficacy of famciclovir in the treatment of herpes zoster. Neurology 1995; 45: S76,77.
Gonzales GR. Central pain. Sem Neurol 1994; 14: 255–262.
Portenoy RK. Neuropathic pain. In: Portenoy RK, Kanner RM, eds. Pain Management: Theory and Practice. Philadelphia: F. A. Davis, 1996; 83–125.
Boivie J, Leijon G. Clinical findings in patients with central poststroke pain. In: Casey KL, ed. Pain and central nervous system disease: the central pain syndromes. New York: Raven, 1991; 65–75.
Casey KL. Pain and central nervous system disease: a summary and overview. In: Casey KL, ed. Pain and central nervous system disease: the central pain syndromes. New York: Raven, 1991; 1–11.
Gonzales GR. Central pain: diagnosis and treatment strategies. Neurology 1995; 45: S11–16.
Beric A. Central pain: “new” syndromes and their evaluation. Muscle & Nerve 1993; 16: 1017–1024.
Boivie J, Leijon G. Pharmacologic treatment of central pain. In: Casey KL, ed. Pain and central nervous system disease: the central pain syndromes. New York: Raven, 1991; 257–266.
Herman RM, D’Luzansky SC, Ippolito R. Intrathecal Baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 1992; 8: 338–345.
Leijon G, Boivie J. Central post-stroke pain—the effect of high and low frequency TENS. Pain 1989; 38: 187–191.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, D.C.: American Psychiatric Association, 1994.
King SA. Review: DSM-IV and pain. Clin J Pain 1995; 11: 171–176.
Lim LEC. Psychogenic pain. Singapore Med J 1994; 35: 519–522.
Pilowsky I, Barrow G. Predictors of outcome in the treatment of chronic “psychogenic” pain with amitriptyline and brief psychotherapy. Clin J Pain 1992; 8: 358–362.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hamilton, M.E. (1998). Pain by Etiology. In: Gershwin, M.E., Hamilton, M.E. (eds) The Pain Management Handbook. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-1796-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1796-1_13
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-7287-8
Online ISBN: 978-1-4612-1796-1
eBook Packages: Springer Book Archive